Aspen Aerogels (NYSE:ASPN) Rating Lowered to Hold at Seaport Res Ptn

Seaport Res Ptn downgraded shares of Aspen Aerogels (NYSE:ASPN - Free Report) from a strong-buy rating to a hold rating in a research note released on Wednesday,Zacks.com reports.

Other equities analysts have also recently issued reports about the stock. Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research note on Friday, November 8th. Canaccord Genuity Group reduced their price objective on shares of Aspen Aerogels from $28.00 to $20.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a research note on Saturday, February 8th. HC Wainwright reaffirmed a "buy" rating and issued a $30.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, October 16th. Finally, Barclays reduced their price objective on shares of Aspen Aerogels from $27.00 to $25.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 12th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $24.67.

Aspen Aerogels Price Performance

Shares of ASPN traded down $0.09 during mid-day trading on Wednesday, hitting $8.55. 2,796,169 shares of the company traded hands, compared to its average volume of 2,151,431. Aspen Aerogels has a one year low of $8.25 and a one year high of $33.15. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business has a 50-day moving average of $12.06 and a 200 day moving average of $18.36. The stock has a market capitalization of $701.12 million, a price-to-earnings ratio of 855.36 and a beta of 2.14.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. As a group, equities analysts expect that Aspen Aerogels will post 0.12 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

Hedge funds have recently bought and sold shares of the company. Lord Abbett & CO. LLC acquired a new stake in Aspen Aerogels in the third quarter worth $10,126,000. Oppenheimer & Co. Inc. raised its holdings in shares of Aspen Aerogels by 167.2% during the third quarter. Oppenheimer & Co. Inc. now owns 102,535 shares of the construction company's stock worth $2,839,000 after acquiring an additional 64,154 shares during the period. Sanders Morris Harris LLC raised its holdings in shares of Aspen Aerogels by 337.5% during the fourth quarter. Sanders Morris Harris LLC now owns 35,000 shares of the construction company's stock worth $436,000 after acquiring an additional 27,000 shares during the period. Penserra Capital Management LLC acquired a new stake in shares of Aspen Aerogels during the third quarter worth $1,342,000. Finally, Geode Capital Management LLC raised its holdings in shares of Aspen Aerogels by 5.7% during the third quarter. Geode Capital Management LLC now owns 1,385,968 shares of the construction company's stock worth $38,385,000 after acquiring an additional 75,024 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.